| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |